New patent expiration for Emd Serono drug MAVENCLADBy DrugPatentWatch – Make Better Decisions / April 11, 2024 Annual Drug Patent Expirations for MAVENCLAD Mavenclad is a drug marketed by Emd Serono Inc and is included in one NDA. It is available from one supplier. There are five…Source